Your browser doesn't support javascript.
loading
A case of sintilimab-induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein-1 inhibitors.
Huang, Ying; Zhu, Lin; Ma, Xiaoying; Hong, Yiyong; Su, Xiangyang; Lai, Wei; Gong, Zijian.
Affiliation
  • Huang Y; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhu L; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Ma X; Department of Oncology, Guangzhou Mordern Hospital, Guangzhou, China.
  • Hong Y; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Su X; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Lai W; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Gong Z; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Dermatol Ther ; 35(9): e15663, 2022 09.
Article in En | MEDLINE | ID: mdl-35739068
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stevens-Johnson Syndrome / Immune Checkpoint Inhibitors Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stevens-Johnson Syndrome / Immune Checkpoint Inhibitors Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2022 Document type: Article Affiliation country: